Macular Degeneration Drug Prescribing Patterns After Step Therapy Introduction in Medicare Advantage.

ABSTRACT:

Importance

In Medicare Advantage (MA), step therapy for physician-administered drugs is an approach to lowering drug spending. The impact of step therapy in MA on prescribing behavior and the magnitude of any changes has not been analyzed.

Objective

To evaluate the impact of step therapy on macular degeneration drug prescribing patterns for 3 large MA insurers.

Design, setting, and participants

This was a retrospective encounter-based analysis using 20% nationally representative MA outpatient and carrier encounter records for 2017 to 2019. Participants were MA beneficiaries who were 65 years or older and had received a macular degeneration drug administration. Macular degeneration drug administrations for beneficiaries of MA Aetna, Humana, and UnitedHealthcare (UHC) i

SUBMITTER: Liu A 

PROVIDER: S-EPMC11316235 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature